Daily Archives: March 2, 2021

Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease

Posted on March 2, 2021 by Gastroenterology Journal

A large unmet therapeutic need exists in inflammatory bowel diseases (IBD). Inhibition of interleukin (IL)-6 appears to be effective, but the therapeutic benefit of a complete IL-6/IL-6R blockade is limited by profound immunosuppression. Evidence has e… Continue reading →

Posted in News | Comments Off on Therapeutic IL-6 trans-signalling inhibition by olamkicept (sgp130Fc) in patients with active inflammatory bowel disease

B lymphocytes contribute to celiac disease pathogenesis

Posted on March 2, 2021 by Gastroenterology Journal
Posted in News | Comments Off on B lymphocytes contribute to celiac disease pathogenesis